https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-07-03 / Int J Cancer 2024 Oct;155(8):1443-1454
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-07-03 / Int J Cancer 2024 Oct;155(8):1443-14542024-07-03 00:00:002024-07-03 00:00:00Personalized dendritic cell vaccine in multimodal individualized combination therapy improves survival in high-risk pediatric cancer patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-07-07 / Neurooncol Adv 2023;5(1):vdad081
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-07-07 / Neurooncol Adv 2023;5(1):vdad0812023-07-07 00:00:002023-07-07 00:00:00Recent oncolytic virotherapy clinical trials outline a roadmap for the treatment of high-grade glioma
https://www.iozk.de/wp-content/uploads/2020/11/IOZK_team_van-gool_175828-ret.jpg
518
690
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2023-01-23 16:08:352023-01-25 16:42:45Stefaan van Gool ist Herausgeber einer Sonderausgabe im Journal of Molecular Sciences
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-12-01 / Transl Pediatr 2022 Dec;11(12):2040-2056
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-12-01 / Transl Pediatr 2022 Dec;11(12):2040-20562022-12-01 00:00:002024-01-30 11:22:05Immunotherapy for the treatment of pediatric brain tumors: a narrative review
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-10-11 / Neuro Oncol 2022 Oct;
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-10-11 / Neuro Oncol 2022 Oct;2022-10-11 00:00:002022-10-11 00:00:00Cellular Immunotherapy for Medulloblastoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-08-24 / Pharmaceutics 2022 Aug;14(9)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-08-24 / Pharmaceutics 2022 Aug;14(9)2022-08-24 00:00:002022-08-24 00:00:00Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-05-19 / Medicines (Basel) 2020 May;7(5)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-05-19 / Medicines (Basel) 2020 May;7(5)2020-05-19 00:00:002021-11-15 20:10:42Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-09-19 / Cancers (Basel) 2019 Sep;11(9)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-09-19 / Cancers (Basel) 2019 Sep;11(9)2019-09-19 00:00:002020-08-26 14:07:32Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-08-01 / Lancet Oncol 2018 08;19(8):e419-e428
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-08-01 / Lancet Oncol 2018 08;19(8):e419-e4282018-08-01 00:00:002021-11-15 19:56:02Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour Group
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-04-26 / Front Oncol 2018;8:127
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-04-26 / Front Oncol 2018;8:1272018-04-26 00:00:002019-02-15 08:34:53Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma
